Webinars

SEP 22, 2015 9:00 AM PDT

WEBINAR: Galectin-3 A Step Towards a Clearer Pathway in Heart Failure Management

Sponsored by: Abbott Molecular Diagnostic, Abbott Molecular Diagnostic

Speaker

Peter A. McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.

Vice Chief of Medicine, Baylor University Medical Center , and Principal Faculty in internal medicine, Texas A & M University Health Sciences Center
BIOGRAPHY

Abstract

DATE: Sept 22, 2015
TIME: 9:00am PDT, 12:00PM EDT

Heart failure is a complex syndrome and affects over 5.1 Million Americans today with approximately 500,000 new heart failure cases each year. Heart failure is the leading cause of emergency room visits, hospitalizations, and death for Americans today. Although, there have been significant advances in heart failure diagnosis, management, and treatment there is still a need for new tools to help optimize the management of this healthcare burden. Recently, novel biomarkers have emerged as additional tools to aid in prognosis and management of heart failure. During today's webcast, we will learn about a new and emerging biomarker called galectin-3 and how it can be used as a management tool for heart failure patients in the US.

Learning Objectives:
• Understand what is galectin-3
• Learn about pathophysiology of cardiac fibrosis and the role of galectin-3
• Comprehend how galectin-3 can used as a management tool for heart failure patients

Who Should Attend:
• Laboratorians
• Heart failure nurses
• Heart failure specialists
• Cardiologists
• Emergency Physicians

WEBINAR: Galectin-3 A Step Towards a Clearer Pathway in Heart Failure Management

Peter A. McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.